MWNA
OPTN

Marshall Wace North America’s OptiNose OPTN Stock Holding History

Marshall Wace North America’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,976
Closed -$844K – 1621
2017
Q4 		$844K Buy
+2,976
New +$837K ﹤0.01% 1027

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Marshall Wace North America's OPTN Position: Q1 2018 in Review

Marshall Wace North America sold out of OptiNose (OPTN) in Q1 2018, closing a stake of 2,976 shares — an estimated $844K sold.

Marshall Wace North America first reported a position in OPTN in Q4 2017 and held it in 1 quarter. The position peaked at $844K in Q4 2017. 49 funds tracked by Wall St. Rank hold OPTN as of Q1 2018.

  • Marshall Wace North America reported no remaining OptiNose position as of Q1 2018 after selling out during the quarter.
  • Marshall Wace North America sold 2,976 OptiNose shares in Q1 2018, an estimated $844K.
  • Marshall Wace North America first reported a position in OptiNose in Q4 2017 and held it in 1 quarter.
  • Marshall Wace North America's OptiNose position peaked at $844K in Q4 2017.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q1 2018.

Based on Marshall Wace North America's 13F filing for Q1 2018, filed 15 May 2018.